A randomized Phase 1b trial evaluating the pharmacodynamics of ilofotase alfa in adults with hypophosphatasia
{{output}}
Hypophosphatasia is a rare genetic disease caused by deficient alkaline phosphatase activity. In adults, this causes functional limitations, substantial disability with pain and reduced quality of life. This Phase 1b, single-center, open-label trial investigat... ...
